Our Vision

To Emerge As A Leading  Integrated Global  Generics Organization 

USA

Glenmark Generics Inc. (GGI), USA is the North American division of Glenmark Generics Ltd. (GGL) dedicated to the manufacture, marketing and distribution of generic pharmaceutical products. Read more.

EUROPE

Glenmark commenced its European operations in the UK in 2004. The generic formulations and API business in Europe has a robust product portfolio developed by a Europe-dedicated R&D team and has excellent supply chain resources. Read more.

ARGENTINA

Glenmark Generics Argentina is the hub for generic research, manufacturing and distribution of oncology products for the whole world. The company’s continuous growth since then now spans 23 countries. Read More.

API

Glenmark API is the Active Pharmaceutical Ingredient manufacturing arm of Glenmark Generics. With a presence in over 80 countries Glenmark's API business is among the top 10 in the Indian Generic Pharmaceutical Market. Read more.

PRESS RELEASES

June 25, 2009:Glenmark Generics receives ANDA approval from the U.S. FDA for Alclometasone Dipropionate Cream Read More

June 01, 2009: Glenmark receives ANDA approval from U.S. FDA for Hydralazine Hydrochloride Tablets Read More


© 2008 Glenmark Generics Ltd.